Non-model models, preprints, and the fruit of the translational tree

Earlier this week the annual meeting of the American Society for Cell Biology was held in San Francisco. In attendance was Associate Editor for BMC Biology, Graham Bell, and here he discusses some of the meeting's highlights, and lessons for 2017

From Wikipedia
Peter Walter, President of the ASCB
From Wikipedia

Oxford Dictionaries has picked “post-truth” as the Word of the Year – what a sorry state of affairs, laments ASCB President Peter Walter, encouraging the community to come together and stand up for science and evidence-based learning. And with that, the 27th annual meeting of the American Society of Cell Biology kicked off in San Francisco.

Always a highlight of the year, the meeting brings together thousands of biologists from across the globe to present and discuss a scope far wider than just cell biology, a theme evident from the fascinating, and in some cases bewildering, range of sessions.

Water bears and virgin births

From Wikipedia
Tardigrades, affectionately known as water bears, are among the hardiest animals on earth
From Wikipedia

In truth, the meeting began before Walter’s introduction, with the ‘special interest’ sub-groups. ‘Special’ should be read as ‘outstanding’ rather than ‘niche’, as talks on non-model model organisms in particular shone. ‘Water bears’ able to survive 1 degree Kelvin temperatures and the vacuum of space; the virgin birth as illuminated by ants and bees; and remarkable regenerative powers of Stentor were just three examples illustrated by speakers where organisms’ quirky features can be used to address unresolved and fascinating questions in biology.

Spreading the message

Perhaps the most important session of the conference, and deserving of a more prominent position, was on the place of preprints in publishing. Prachee Avasthi and ASAPBio director Jessica Polka were joined by a diverse cast of new and established scientists, editors and tool-builders, including bioRxiv founders Richard Sever and John Inglis, to explain how best to use – and promote – servers allowing immediate and free distribution of research findings.

Researchers, funding agencies and journals all have parts to play in promoting preprints

BioRxiv, one of the major preprint servers for biology research
BioRxiv, one of the major servers hosting free preprints in the life sciences
From Wikipedia

A key message was how to integrate preprints into the ‘established’ model of disseminating science, and the need for a combined effort from funders and grants agencies, journals and scientists to reach critical mass faster than will already inevitably happen.

“Dark matter” literature

(At this juncture we should say of course that BMC Biology is very happy to consider preprints for submission, citation, ‘proof of priority’ – and should have news on our own integration with preprint servers soon – watch this space!)

For those already au fait with preprint servers, a talk by Ansuman Chattopadhyay highlighting search tools – infrastructure essential to navigate this growing resource, like those from HSLS and OSF  – was especially useful.

The limitations of being normal

There is no such thing as ‘applied science’ – just science, and its applications

On the science side, much emphasis was placed on integrating basic (or, better, ‘fundamental’) cell biology with applied and clinical medicine – or as Anne Bertolotti quoted Louis Pasteur: ‘“There does not exist a category of science to which one can give the name applied science. There are science and the applications of science, bound together as the fruit of the tree which bears it.”’

Sequencing patient tissues informs cell biology in health and disease
Sequencing patient tissues informs cell biology in health and disease
From BMC Medicine

Joseph Gleeson emphasised that “there’s only so much we can learn from studying ‘normal’” and how sequencing patient tissues informs cell biology, which in turn allows us to better characterise, diagnose and treat disease (in this case in neural development); whilst Laurie Glimcher of Dana Farber, in a tour de force on the history and current state of cancer immunotherapy noted that we are failing to overcome the multi-layered ‘tumour microenvironment blockade’, and called for the transformation of cancer into a chronic disease, with cell biology forming the basis of combination treatments.

Complemented by superb talks from graduate students and mammoth but surprisingly navigable poster sessions, the meeting provided an excellent platform to look forward to 2017 in science (and, hopefully, a more positive word-of-the-year).

Graham Bell

Senior Editor at BMC Biology
Graham received a PhD in Developmental Biology from UCL/Cancer Research UK in 2014. He joined BMC in 2015 to become a member of BMC Biology's editorial team, where he is a Senior Editor.

View the latest posts on the On Biology homepage